頭蓋内ステント総対応市場：タイプ、用途、エンドユーザー別-2025-2030年の世界予測

頭蓋内ステント総対応市場は、2023年に29億2,000万米ドルと評価され、2024年には30億4,000万米ドルに達すると予測され、CAGR 5.61％で成長し、2030年には42億8,000万米ドルに達すると予測されています。

頭蓋内ステントは、弱くなった血管壁を支え、血流を促進し、脳内の潜在的な閉塞を防ぐことによって、脳血管疾患を治療するために設計された重要な装置です。この市場には、動脈瘤の修復や虚血性脳卒中の回復など、さまざまな神経学的処置用に設計された自己拡張型ステントやバルーン拡張型ステントなど、さまざまなタイプのステントが含まれます。これらのステントの必要性は、神経疾患の有病率の上昇、世界人口の高齢化、脳卒中リスクを高める高血圧や糖尿病などの生活習慣病の発生率の増加によって強調されています。その用途は病院、神経科専門クリニック、外来手術センターなど多岐にわたるが、これは高度な医療介入と長期的な患者ケアにおける重要な役割を反映しています。この市場に影響を与える主な成長要因には、柔軟性を向上させるステント設計の発展や、潜在的な副作用を最小限に抑えるコーティング材料などの技術革新があります。さらに、ヘルスケア支出の増加、脳卒中予防の意識、低侵襲手術の進歩が市場の成長をさらに後押ししています。好機は、アフターケアのための遠隔医療の拡大、生体材料研究によるステント設計の強化、医療ニーズが満たされていない新興市場への参入にあります。とはいえ、市場成長は厳しい規制環境、ステント処置の高コスト、複雑な神経学的介入に対応できる熟練した専門家の不足といった課題に直面しています。また、サプライチェーンの混乱や競争圧力も市場制約に拍車をかけています。技術革新のための最良の分野としては、リアルタイムモニタリング用の統合センサーを備えたスマートステントや、個々の患者のニーズに合わせた治療を行う個別化医療戦略の開発が挙げられます。頭蓋内ステント市場は急速な技術進歩と市場競争の激しさが特徴であり、事業成長のためには継続的な調査と戦略的提携が必要であるため、こうした力学を理解することは極めて重要です。このような洞察力を活用することで、企業は市場の課題を巧みに乗り切ると同時に、急成長する技術革新と事業拡大の機会を活用することができます。

市場力学：急速に進化する頭蓋内ステント総対応市場の主要市場インサイトを公開

頭蓋内ステント総対応市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の頭蓋内疾患の有病率の増加
  • 低侵襲頭蓋内手術への嗜好の高まり
  • 診断率の増加
• 市場抑制要因
  • 頭蓋内ステント手術に伴う副作用
• 市場機会
  • 研究機関による新たな臨床試験と調査
  • 継続的な製品開発と強化
• 市場の課題
  • 適格で熟練した専門家の不足

ポーターのファイブフォース：頭蓋内ステント総対応市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：頭蓋内ステント総対応市場における外部からの影響の把握

外部マクロ環境要因は、頭蓋内ステント総対応市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析頭蓋内ステント総対応市場における競合情勢の把握

頭蓋内ステント総対応市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス頭蓋内ステント総対応市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、頭蓋内ステント総対応市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨頭蓋内ステント総対応市場における成功への道筋を描く

頭蓋内ステント総対応市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で頭蓋内疾患の罹患率が増加
    • 低侵襲頭蓋内手術への関心の高まり
    • 診断率の増加
  • 抑制要因
    • 頭蓋内ステント手術に伴う副作用
  • 機会
    • 調査機関による新たな臨床試験と研究
    • 継続的な製品開発と強化
  • 課題
    • 資格とスキルのある専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 頭蓋内ステント総対応市場：タイプ別

• バルーン拡張ステント
• 自己拡張型ステント
• ステント補助コイル塞栓術

第7章 頭蓋内ステント総対応市場：用途別

• 脳動脈瘤
• 頭蓋内狭窄

第8章 頭蓋内ステント総対応市場：エンドユーザー別

• 外来手術センター
• 病院

第9章 南北アメリカの頭蓋内ステント総対応市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の頭蓋内ステント総対応市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの頭蓋内ステント総対応市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acandis GmbH
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• MicroPort Scientific Corporation
• optimed Medizinische Instrumente GmbH
• Sino Medical Sciences Technology Inc.
• Stryker Corporation
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET RESEARCH PROCESS
• FIGURE 2. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET DYNAMICS
• TABLE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023

The Intracranial Stents Total Addressable Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.04 billion in 2024, and is projected to grow at a CAGR of 5.61%, to USD 4.28 billion by 2030.

Intracranial stents are vital devices designed to treat cerebrovascular diseases by providing support to weakened blood vessel walls, facilitating blood flow, and preventing potential blockages within the brain. The scope of this market encompasses various stent types, including self-expanding and balloon-expandable stents, designed for diverse neurological procedures such as aneurysm repair and ischemic stroke recovery. The necessity of these stents is underscored by the rising prevalence of neurological disorders, an aging global population, and the increasing incidence of lifestyle-related conditions like hypertension and diabetes, which elevate stroke risks. Their application spans hospitals, specialized neurology clinics, and ambulatory surgical centers, reflecting their critical role in advanced medical interventions and long-term patient care. Key growth factors influencing this market include technological innovations, such as developments in stent design for improved flexibility and coating materials that minimize potential side effects. Furthermore, increased healthcare spending, awareness of stroke prevention, and advancements in minimally invasive procedures further bolster market growth. Opportunities lie in expanding telemedicine for aftercare, enhancing stent design through biomaterial research, and accessing emerging markets with unmet healthcare needs. Nevertheless, market growth faces challenges including stringent regulatory environments, the high cost of stent procedures, and limited skilled professionals for complex neurological interventions. Supply chain disruptions and competitive pressures also add to market constraints. The best areas for innovation involve the development of smart stents with integrated sensors for real-time monitoring and personalized medicine strategies that tailor treatments to individual patient needs. Understanding these dynamics is crucial as the intracranial stents market is characterized by rapid technological advancements and competitive intensity, necessitating continuous research and strategic partnerships for business growth. By leveraging these insights, firms can adeptly navigate market challenges while capitalizing on burgeoning opportunities for innovation and expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Stents Total Addressable Market

The Intracranial Stents Total Addressable Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of intracranial disease across the globe
  • Rising preference for minimally invasive intracranial surgeries
  • Increase in number of diagnostic rates
• Market Restraints
  • Associated adverse effects of intracranial stents surgeries
• Market Opportunities
  • Emerging clinical trials and studies by research organizations
  • Ongoing product development and enhancement
• Market Challenges
  • Lack of qualified and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Stents Total Addressable Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Stents Total Addressable Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Stents Total Addressable Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Stents Total Addressable Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Stents Total Addressable Market

A detailed market share analysis in the Intracranial Stents Total Addressable Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Stents Total Addressable Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Stents Total Addressable Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intracranial Stents Total Addressable Market

A strategic analysis of the Intracranial Stents Total Addressable Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Stents Total Addressable Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic PLC, MicroPort Scientific Corporation, optimed Medizinische Instrumente GmbH, Sino Medical Sciences Technology Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Stents Total Addressable Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Balloon Expanding Stents, Self-Expanding Stents, and Stent-Assisted Coil Embolization.
• Based on Application, market is studied across Brain Aneurysm and Intracranial Stenosis.
• Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of intracranial disease across the globe
    • 5.1.1.2. Rising preference for minimally invasive intracranial surgeries
    • 5.1.1.3. Increase in number of diagnostic rates
  • 5.1.2. Restraints
    • 5.1.2.1. Associated adverse effects of intracranial stents surgeries
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging clinical trials and studies by research organizations
    • 5.1.3.2. Ongoing product development and enhancement
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of qualified and skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intracranial Stents Total Addressable Market, by Type

• 6.1. Introduction
• 6.2. Balloon Expanding Stents
• 6.3. Self-Expanding Stents
• 6.4. Stent-Assisted Coil Embolization

7. Intracranial Stents Total Addressable Market, by Application

• 7.1. Introduction
• 7.2. Brain Aneurysm
• 7.3. Intracranial Stenosis

8. Intracranial Stents Total Addressable Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals

9. Americas Intracranial Stents Total Addressable Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Intracranial Stents Total Addressable Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Stents Total Addressable Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Johnson & Johnson Services, Inc.
• 4. Medtronic PLC
• 5. MicroPort Scientific Corporation
• 6. optimed Medizinische Instrumente GmbH
• 7. Sino Medical Sciences Technology Inc.
• 8. Stryker Corporation
• 9. Terumo Corporation